Hot Stocks You're Buying Now

Welcome back to another Foolish review of the hottest stocks as ranked by Motley Fool CAPS. We're looking at the three best-performing industries over the past 30 days and your favorite long and short candidates in each.

Has the cancellation crisis spread beyond American Airlines? I ask because the travel services sector, last week's champ is today's second-place finisher, with a 29.8% average return.

But that can't touch the returns diagnostic substances manufacturers are producing. Immucor (Nasdaq: BLUD  ) , Human Genome Sciences (Nasdaq: HGSI  ) , and their peers are up 67.2% as a group since mid-March.

Finally, stocks based in Cambridge, Mass., within spitting distance of Harvard Yard -- Akamai Technologies (Nasdaq: AKAM  ) , for example -- are up 21.6% over the past month.

According to you, our Foolish readers, the best stocks in these industries to own now -- i.e., those with four or five of the maximum five stars in CAPS -- are:

Company

CAPS Stars

No. of CAPS Ratings

Percent Bulls

30-Day Price Change

IDEXX Laboratories (NASDAQ:IDXX)

*****

149

98.7%

(3.1%)

Meridian Bioscience (NASDAQ:VIVO)

*****

407

98.5%

11.8%

Neogen (NASDAQ:NEOG)

*****

206

98.1%

2%

Sources: Motley Fool CAPS, Yahoo! Finance (current as of 4/11).

And your favorite short candidates -- i.e., those rated with one or two stars in CAPS -- are:

Company

CAPS Stars

No. of CAPS Ratings

Percent Bears

30-Day Price Change

Nymox Pharmaceutical (NASDAQ:NYMX)

*

60

50%

(5.1%)

Sources: Motley Fool CAPS, Yahoo! Finance (current as of 4/11).

My favorite stock among today's contenders is pet medicine maker IDEXX Labs, for all the same reasons CAPS investor every1mustpay gave in this pitch from last month. Quoting:

IDEXX Labs is a one of a kind company in that it specializes in the one area where people spare no expense, their pets. Regardless of market and economic conditions people will continue to spend money on pets.

History bears witness to his thesis. Fool alamobull, a top scorer for IDEXX, explained it this way last January:

Mid cap growth, 10%+ rev growth [year-over-year] for last 10 years, + [free cash flow], +10% [earnings per share] growth [year-over-year] for last 10 years. ... Non-cyclical business (veterinary, food, agriculture)

Even so, with a 1.77 PEG ratio based on 2008 projected earnings, IDEXX isn't cheap. But that's to be expected -- high-growth, non-cyclical stocks are never easy to find, and this one, with its double-digit returns on equity and capital, appears worth the premium.

But that's my take. What would you do? Would you buy IDEXX at today's prices? Let us know what you think by signing up for CAPS today. It's 100% free to participate.

Cap off your day with related CAPS Foolishness:


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 620666, ~/Articles/ArticleHandler.aspx, 4/24/2014 11:57:24 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement